Volume 64, Issue 6, Pages (December 2003)

Slides:



Advertisements
Similar presentations
Parathyroidectomy: Whom and when?
Advertisements

Acid-base profile in patients on PD
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Melamine toxicity: one more culprit in calcium kidney lithiasis
Volume 67, Pages S1-S7 (June 2005)
Acid-base profile in patients on PD
Volume 68, Issue 6, Pages (December 2005)
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Volume 67, Issue 2, Pages (February 2005)
Parathyroidectomy: Whom and when?
Volume 63, Pages S88-S90 (June 2003)
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 70, Pages S12-S15 (July 2006)
Cell apoptosis and hemodialysis-induced inflammation
A new era in phosphate binder therapy: What are the options?
Volume 70, Issue 11, Pages (December 2006)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Nephrology Crosswords: Hemodialysis
Use of vitamin D in chronic kidney disease patients
Volume 87, Issue 2, Pages (February 2015)
Chemical and hormonal determinants of vascular calcification in vitro
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease  S. Bianchi, R. Bigazzi, V.M. Campese 
Ewa Lewin, Yolanda Almaden, Mariano Rodriguez, Klaus Olgaard 
Volume 80, Issue 5, Pages (September 2011)
Metabolic acidosis inhibits soft tissue calcification in uremic rats
Volume 70, Issue 12, Pages (December 2006)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Role of vitamin D receptor activators on cardiovascular risk
Volume 143, Issue 6, (December 2010)
Volume 56, Pages S31-S37 (December 1999)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 55, Issue 4, Pages (April 1999)
Volume 60, Issue 1, Pages (July 2001)
Volume 87, Issue 3, Pages (March 2015)
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
Volume 56, Issue 4, Pages (October 1999)
Pathogenesis of refractory secondary hyperparathyroidism
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Volume 75, Issue 9, Pages (May 2009)
A man with a hole in his penis
Volume 82, Issue 9, Pages (November 2012)
Volume 54, Issue 1, Pages (July 1998)
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Phosphate binders on iron basis: A new perspective?
Organ transplantation goes to the movies
Volume 72, Issue 2, Pages (July 2007)
Volume 80, Issue 10, Pages (November 2011)
Volume 60, Issue 6, Pages (December 2001)
Volume 68, Pages S98-S102 (December 2005)
Volume 70, Issue 3, Pages (August 2006)
Volume 64, Issue 1, Pages (July 2003)
Volume 70, Issue 5, Pages (September 2006)
Volume 62, Issue 5, (November 2002)
Volume 56, Issue 1, Pages (July 1999)
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
Volume 54, Issue 6, Pages (January 1998)
The International Pediatric Peritonitis Registry: Starting to walk
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Increased fetuin-A levels following treatment with a vitamin D analog
Volume 60, Issue 5, Pages (November 2001)
Volume 55, Issue 4, Pages (April 1999)
Volume 61, Issue 4, Pages (April 2002)
A. Khwaja, C.C. Sharpe, M. Noor, B.M. Hendry  Kidney International 
Volume 87, Issue 6, Pages (June 2015)
Volume 55, Issue 5, Pages (May 1999)
Atrial fibrillation in incident dialysis patients
Presentation transcript:

Volume 64, Issue 6, Pages 2311-2317 (December 2003) Proliferation in hyperplastic human and normal rat parathyroid glands: Role of phosphate, calcitriol, and gender  Yolanda Almaden, Arnold J. Felsenfeld, Mariano Rodriguez, Sagrario Cañadillas, Fernando Luque, Alicia Bas, Juan Bravo, Vicente Torregrosa, Alfonso Palma, Blanca Ramos, Carmen Sanchez, Alejandro Martin-Malo, Antonio Canalejo  Kidney International  Volume 64, Issue 6, Pages 2311-2317 (December 2003) DOI: 10.1046/j.1523-1755.2003.00331.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 The effect of pre-PTX serum phosphate values on human parathyroid cell proliferation in vitro. Cell proliferation (% cells in S phase) was determined in parathyroid tissue from 47 glands (from 19 patients) incubated for 24hours in medium without (dark bars) or with (white bars) 10−7 mol/L calcitriol. Groups are divided by the mean pre-PTX serum phosphate value (6.3mg/dL). Values for percent cells in S phase are given as the mean ± SE. *P < 0.01 vs. (-calcitriol); #P < 0.05 vs. (+calcitriol) of serum phosphate <6.3mg/dL. Kidney International 2003 64, 2311-2317DOI: (10.1046/j.1523-1755.2003.00331.x) Copyright © 2003 International Society of Nephrology Terms and Conditions